Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice

nork Ravaud, A, Bedane, C, Geoffrois, L, Lesimple, T, Delaunay, M
Argitaratua 1999

EPOCK study protocol: a mixed-methods research program evaluating cancer care coordination nursing occupations in France as a complex intervention

nork Colombani, F., Sibé, M., Kret, M., Quintard, B., Ravaud, A., Saillour-Glénisson, F.
Argitaratua izan da BMC Health Serv Res (2019)

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

nork Calès, P, Grasset, D, Ravaud, A, Meskens, C, Blanc, M, Vinel, J P, Cotonat, J, Pascal, J P
Argitaratua 1989

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

nork Calès, P, Desmorat, H, Vinel, J P, Caucanas, J P, Ravaud, A, Gerin, P, Brouet, P, Pascal, J P
Argitaratua 1990

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.

nork Ravaud, A., Négrier, S., Cany, L., Merrouche, Y., Le Guillou, M., Blay, J. Y., Clavel, M., Gaston, R., Oskam, R., Philip, T.
Argitaratua 1994

A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma.

nork Ravaud, A., Legrand, E., Delaunay, M. M., Bussières, E., Coulon, V., Cany, L., Huet, S., Verdier, D., Kind, M., Chomy, F.
Argitaratua 1995

Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial

nork Ravaud, A, Delaunay, M, Chevreau, C, Coulon, V, Debled, M, Bret-Dibat, C, Courbon, F, Gualde, N, Bui, B Nguyen
Argitaratua 2001

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II t...

nork Ravaud, A, Trufflandier, N, Ferrière, J M, Debled, M, Palussière, J, Cany, L, Gaston, R, Mathoulin-Pélissier, S, Bui, B N
Argitaratua 2003

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.

nork Ravaud, A., Bui, N. B., Coindre, J. M., Lagarde, P., Tramond, P., Bonichon, F., Stöckle, E., Kantor, G., Trojani, M., Chauvergne, J.
Argitaratua 1992

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy

nork Rugo, H. S., Hortobagyi, G. N., Yao, J., Pavel, M., Ravaud, A., Franz, D., Ringeisen, F., Gallo, J., Rouyrre, N., Anak, O., Motzer, R.
Argitaratua izan da Ann Oncol (2016)

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

nork Bracarda, S, Hutson, T E, Porta, C, Figlin, R A, Calvo, E, Grünwald, V, Ravaud, A, Motzer, R, Kim, D, Anak, O, Panneerselvam, A, Escudier, B
Argitaratua 2012

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial

nork Staehler, M, Motzer, R J, George, D J, Pandha, H S, Donskov, F, Escudier, B, Pantuck, A J, Patel, A, DeAnnuntis, L, Bhattacharyya, H, Ramaswamy, K, Zanotti, G, Lin, X, Lechuga, M, Serfass, L, Paty, J, Ravaud, A
Argitaratua izan da Ann Oncol (2018)

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

nork Motzer, R.J., Tannir, N.M., McDermott, D.F., Frontera, O. Arén, Melichar, B., Choueiri, T.K., Plimack, E.R., Barthélémy, P., Porta, C., George, S., Powles, T., Donskov, F., Neiman, V., Kollmannsberger, C.K., Salman, P., Gurney, H., Hawkins, R., Ravaud, A., Grimm, M.-O., Bracarda, S., Barrios, C.H., Tomita, Y., Castellano, D., Rini, B.I., Chen, A.C., Mekan, S., McHenry, M.B., Wind-Rotolo, M., Doan, J., Sharma, P., Hammers, H.J., Escudier, B.
Argitaratua izan da N Engl J Med (2018)